FDA Inspection 872380 — Legacy Health IRB

Legacy Health IRB — FEI 3023464

The FDA completed an inspection of Legacy Health IRB on April 3, 2014 in Portland, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 3, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Portland, OR (United States)

Additional Details

IRB

Citations

IDCFRDescription
727621 CFR 56.107(c)One scientific and one non-scientific member
727821 CFR 56.107(e)Conflict of interest
728121 CFR 56.108(a)(1)Initial and continuing reviews
731821 CFR 56.115(a)(2)Minutes of IRB meetings
733421 CFR 56.115(a)(5)List of members
736921 CFR 56.109(h)Children as subjects